| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/NM870 |
| P953 | full work available at URL | http://www.nature.com/articles/nm870 |
| http://www.nature.com/articles/nm870.pdf | ||
| P3181 | OpenCitations bibliographic resource ID | 4912611 |
| P698 | PubMed publication ID | 12740569 |
| P2093 | author name string | Chung Lee | |
| Jayme Borensztajn | |||
| Susan E. Crawford | |||
| Anders R. J. Bergh | |||
| Jennifer A. Doll | |||
| Lisa P. Abramson | |||
| Michael R. Pins | |||
| Mona L. Cornwell | |||
| Noël P. Bouck | |||
| Veronica M. Stellmach | |||
| P2860 | cites work | Cancer Research | Q326097 |
| Thrombospondin-1, vascular endothelial growth factor and fibroblast growth factor-2 are key functional regulators of angiogenesis in the prostate | Q77359737 | ||
| Transplacental carcinogenesis by stilbestrol | Q95784569 | ||
| Cancer surveys | Q27710283 | ||
| Pigment epithelium-derived factor: a potent inhibitor of angiogenesis | Q28139159 | ||
| PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity | Q28241023 | ||
| Wilms' tumor growth is suppressed by antiangiogenic pigment epithelium-derived factor in a xenograft model | Q28513035 | ||
| Thrombospondin-1 is a major activator of TGF-beta1 in vivo | Q28513856 | ||
| Pigment epithelium-derived factor (PEDF) protects motor neurons from chronic glutamate-mediated neurodegeneration | Q28581050 | ||
| Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis | Q29547178 | ||
| Insulin-promoter-factor 1 is required for pancreas development in mice | Q29619695 | ||
| Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factor | Q33556391 | ||
| What might a stromal response mean to prostate cancer progression? | Q33715210 | ||
| A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin | Q33763790 | ||
| Hypoxia, clonal selection, and the role of HIF-1 in tumor progression | Q33924693 | ||
| Growth factors and epithelial-stromal interactions in prostate cancer development | Q33955332 | ||
| The effects of androgen deprivation on the prostate gland: cell death mediated by vascular regression | Q34045475 | ||
| Adipose tissue mass can be regulated through the vasculature | Q34075818 | ||
| Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor | Q34477473 | ||
| PEDF: anti-angiogenic guardian of ocular function | Q34735268 | ||
| Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line | Q40864608 | ||
| Vascular endothelial growth factor is up-regulated in vitro and in vivo by androgens | Q40999561 | ||
| How tumors become angiogenic | Q41100541 | ||
| Regulation of the erythropoietin gene: evidence that the oxygen sensor is a heme protein | Q41337564 | ||
| Analysis of EPC-1 growth state-dependent expression, specificity, and conservation of related sequences | Q41391791 | ||
| Rapid reduction in blood flow to the rat ventral prostate gland after castration: preliminary evidence that androgens influence prostate size by regulating blood flow to the prostate gland and prostatic endothelial cell survival | Q47284047 | ||
| Increased hypoxia correlates with increased expression of the angiogenesis marker vascular endothelial growth factor in human prostate cancer. | Q51360163 | ||
| Induction of pancreatic differentiation by signals from blood vessels. | Q52129124 | ||
| Liver organogenesis promoted by endothelial cells prior to vascular function. | Q52129125 | ||
| Establishment of a new prostatic carcinoma cell line (TSU-Pr1). | Q53437280 | ||
| Pigment epithelium-derived factor is a survival factor for cerebellar granule cells in culture | Q72261159 | ||
| Vascular endothelial growth factor-A expression in the rat ventral prostate gland and the early effects of castration | Q73747740 | ||
| Decrement of blood flow precedes the involution of the ventral prostate in the rat after castration | Q73888363 | ||
| Is tissue mass regulated by vascular endothelial cells? Prostate as the first evidence | Q74117267 | ||
| Testosterone stimulates angiogenesis and vascular regrowth in the ventral prostate in castrated adult rats | Q74117283 | ||
| Early effects of castration on the vascular system of the rat ventral prostate gland | Q74657635 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pancreas | Q9618 |
| eye proteins | Q76799283 | ||
| Serine (or cysteine) peptidase inhibitor, clade F, member 1 | Q21987846 | ||
| P304 | page(s) | 774–780 | |
| P577 | publication date | 2003-05-12 | |
| 2003-06-01 | |||
| P1433 | published in | Nature Medicine | Q1633234 |
| P1476 | title | Pigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreas | |
| Pigment epithelium–derived factor regulates the vasculature and mass of the prostate and pancreas | |||
| P478 | volume | 9 |
| Q39797139 | 'Loss of pigment epithelium-derived factor enables migration, invasion and metastatic spread of human melanoma'. |
| Q35094199 | A PEDF-derived peptide inhibits retinal neovascularization and blocks mobilization of bone marrow-derived endothelial progenitor cells |
| Q83021102 | A gene locus responsible for reticulate pigmented anomaly of the flexures maps to chromosome 17p13.3. |
| Q41956895 | A mouse model for human osteogenesis imperfecta type VI. |
| Q36642793 | AAV-mediated gene transfer of human pigment epithelium-derived factor inhibits Lewis lung carcinoma growth in mice |
| Q28477836 | Alzheimer's disease and non-demented high pathology control nonagenarians: comparing and contrasting the biochemistry of cognitively successful aging |
| Q33607836 | Androgen receptor targets NFkappaB and TSP1 to suppress prostate tumor growth in vivo. |
| Q37093590 | Angiogenesis in eye disease: immunity gained or immunity lost? |
| Q34882979 | Angiogenesis in interstitial lung diseases: a pathogenetic hallmark or a bystander? |
| Q36949560 | Angiogenesis inhibitors and the need for anti-angiogenic therapeutics. |
| Q35521647 | Angiogenesis: a curse or cure? |
| Q42467882 | Angiopoietin 2 expression is related to histological grade, vascular density, metastases, and outcome in prostate cancer |
| Q59409627 | Animal models of osteogenesis imperfecta: applications in clinical research |
| Q37238522 | Anti-tumor effect of adenovirus-mediated gene transfer of pigment epithelium-derived factor on mouse B16-F10 melanoma |
| Q28067001 | Anti-tumor effects of pigment epithelium-derived factor (PEDF): implication for cancer therapy. A mini-review |
| Q57145837 | Antiangiogenic and antifibrogenic activity of pigment epithelium-derived factor (PEDF) in bile duct-ligated portal hypertensive rats |
| Q45876507 | Antiangiogenic property of pigment epithelium-derived factor in hepatocellular carcinoma |
| Q36905311 | Antitumor activity of placenta-derived mesenchymal stem cells producing pigment epithelium-derived factor in a mouse melanoma model |
| Q51728124 | Augmented expression and secretion of adipose-derived pigment epithelium-derived factor does not alter local angiogenesis or contribute to the development of systemic metabolic derangements. |
| Q38169142 | Biomarkers in diabetic retinopathy and the therapeutic implications |
| Q35937569 | Blood vessel signals during development and beyond |
| Q35091440 | Changes in the gene expression profile of A375 human melanoma cells induced by overexpression of multifunctional pigment epithelium-derived factor |
| Q36965062 | Co-expression of KLK6 and KLK10 as prognostic factors for survival in pancreatic ductal adenocarcinoma |
| Q33770029 | Codon preference optimization increases heterologous PEDF expression |
| Q33237201 | Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed Alzheimer's disease and non-demented elderly subjects |
| Q33640617 | Constitutive overexpression of pigment epithelium-derived factor inhibition of ocular melanoma growth and metastasis |
| Q30405866 | Contemporary Approaches for Identifying Rare Bone Disease Causing Genes |
| Q46192807 | Cytosolic phospholipase A2-{alpha} is an early apoptotic activator in PEDF-induced endothelial cell apoptosis |
| Q64092810 | DGAT1 Inhibitor Suppresses Prostate Tumor Growth and Migration by Regulating Intracellular Lipids and Non-Centrosomal MTOC Protein GM130 |
| Q60960330 | Decreased PEDF Expression Promotes Adipogenic Differentiation through the Up-Regulation of CD36 |
| Q47849911 | Decreased expression of pigment epithelium derived factor (PEDF), an inhibitor of angiogenesis, in placentas of unexplained stillbirths. |
| Q37245971 | Determination of mesenchymal stem cell fate by pigment epithelium-derived factor (PEDF) results in increased adiposity and reduced bone mineral content |
| Q54264668 | Downregulation of pigment epithelium-derived factor in condyloma acuminatum. |
| Q34769708 | Effects of hormone deprivation and 2-methoxyestradiol combination therapy on hormone-dependent prostate cancer in vivo |
| Q39342346 | Effects of pigment epithelium derived factor (PEDF) on malignant peripheral nerve sheath tumours (MPNSTs). |
| Q36805395 | Endothelial cells support the growth of prostate tissue in vivo |
| Q33708754 | Ethanol exposure depletes hepatic pigment epithelium-derived factor, a novel lipid regulator |
| Q49386887 | Evaluation of VEGF and PEDF in prostate cancer: A preliminary study in serum and biopsies |
| Q24594147 | Exome sequencing identifies truncating mutations in human SERPINF1 in autosomal-recessive osteogenesis imperfecta |
| Q48224814 | Expression pattern of Vasohibin during chick development |
| Q40252978 | Gene transfer of pigment epithelium-derived factor suppresses tumor growth and angiogenesis in a hepatoblastoma xenograft model |
| Q35995196 | Ginsenoside Rb1 inhibits tube-like structure formation of endothelial cells by regulating pigment epithelium-derived factor through the oestrogen beta receptor |
| Q37351006 | Host pigment epithelium-derived factor (PEDF) prevents progression of liver metastasis in a mouse model of uveal melanoma |
| Q34211707 | Hypoxia negatively regulates antimetastatic PEDF in melanoma cells by a hypoxia inducible factor-independent, autophagy dependent mechanism |
| Q41655399 | Identification of PLXDC1 and PLXDC2 as the transmembrane receptors for the multifunctional factor PEDF. |
| Q34772089 | Identification of a Hoxc8-regulated transcriptional network in mouse embryo fibroblast cells |
| Q30541868 | Identification of a mutation causing deficient BMP1/mTLD proteolytic activity in autosomal recessive osteogenesis imperfecta |
| Q35096644 | Identification of a novel inhibitor of the canonical Wnt pathway |
| Q36027064 | Identification of pigment epithelium-derived factor protein forms with distinct activities on tumor cell lines |
| Q37634555 | In vitro and in vivo biological activity of PEDF against a range of tumors. |
| Q26851186 | Inflammation and metabolic dysfunction: links to cardiovascular diseases |
| Q40141313 | Inhibition of orthotopic osteosarcoma growth and metastasis by multitargeted antitumor activities of pigment epithelium-derived factor |
| Q36538936 | Inhibition of tumor cell surface ATP synthesis by pigment epithelium-derived factor: implications for antitumor activity |
| Q38742179 | Innovative biomarkers for predicting type 2 diabetes mellitus: relevance to dietary management of frailty in older adults. |
| Q24644856 | Laminin receptor involvement in the anti-angiogenic activity of pigment epithelium-derived factor |
| Q92603209 | Lipid droplet velocity is a microenvironmental sensor of aggressive tumors regulated by V-ATPase and PEDF |
| Q47181473 | Long-Term Effects of Weight Loss and Exercise on Biomarkers Associated with Angiogenesis |
| Q37531200 | Loss of pigment epithelium-derived factor: a novel mechanism for the development of endocrine resistance in breast cancer |
| Q37385278 | Mass spectrometry (LC-MS/MS) site-mapping of N-glycosylated membrane proteins for breast cancer biomarkers. |
| Q64275334 | Mechanisms Underlying the Visual Benefit of Cell Transplantation for the Treatment of Retinal Degenerations |
| Q37013230 | Metformin inhibits prostate cancer cell proliferation, migration, and tumor growth through upregulation of PEDF expression |
| Q21266593 | Molecular phylogeny of the antiangiogenic and neurotrophic serpin, pigment epithelium derived factor in vertebrates |
| Q64279530 | Natural killer cells and pigment epithelial-derived factor control the infiltrative and nodular growth of hepatic metastases in an Orthotopic murine model of ocular melanoma |
| Q26864752 | New genes in bone development: what's new in osteogenesis imperfecta |
| Q37889113 | New perspectives on osteogenesis imperfecta |
| Q28565289 | Nuclear receptor co-repressor is required to maintain proliferation of normal intestinal epithelial cells in culture and down-modulates the expression of pigment epithelium-derived factor |
| Q46031481 | Osteogenesis imperfecta, an ever-expanding conundrum. |
| Q35097453 | Overexpression of pigment epithelium-derived factor decreases angiogenesis and inhibits the growth of human malignant melanoma cells in vivo |
| Q27026916 | PEDF and its roles in physiological and pathological conditions: implication in diabetic and hypoxia-induced angiogenic diseases |
| Q37656043 | PEDF expression regulates the proangiogenic and proinflammatory phenotype of the lung endothelium |
| Q33558122 | PEDF increases the tumoricidal activity of macrophages towards prostate cancer cells in vitro |
| Q41354166 | PEDF inhibits pancreatic tumorigenesis by attenuating the fibro-inflammatory reaction |
| Q36277704 | PEDF is a novel oligodendrogenic morphogen acting on the adult SVZ and corpus callosum |
| Q42553869 | PEDF-deficient mice exhibit an enhanced rate of retinal vascular expansion and are more sensitive to hyperoxia-mediated vessel obliteration |
| Q28191537 | PEDF: a multifaceted neurotrophic factor |
| Q44253336 | Periprostatic adipose tissue from obese prostate cancer patients promotes tumor and endothelial cell proliferation: a functional and MR imaging pilot study |
| Q39347364 | Peritumoral expression of adipokines and fatty acids in breast cancer |
| Q36157238 | Pigment Epithelium-Derived Factor (PEDF) Inhibits Wnt/β-catenin Signaling in the Liver |
| Q90452580 | Pigment Epithelium-Derived Factor (PEDF) as a Regulator of Wound Angiogenesis |
| Q95293192 | Pigment Epithelium-derived factor (PEDF) and PEDF-Receptor in the adult mouse brain: Differential spatial/temporal localization pattern |
| Q28255757 | Pigment epithelium-derived factor (PEDF) as a therapeutic target in cardiovascular disease |
| Q34058474 | Pigment epithelium-derived factor (PEDF) interacts with transportin SR2, and active nuclear import is facilitated by a novel nuclear localization motif |
| Q35371579 | Pigment epithelium-derived factor (PEDF) promotes tumor cell death by inducing macrophage membrane tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). |
| Q39905772 | Pigment epithelium-derived factor and interleukin-6 control prostate neuroendocrine differentiation via feed-forward mechanism. |
| Q24632971 | Pigment epithelium-derived factor and its phosphomimetic mutant induce JNK-dependent apoptosis and p38-mediated migration arrest |
| Q36654220 | Pigment epithelium-derived factor as a multifunctional antitumor factor |
| Q39609086 | Pigment epithelium-derived factor associates with neuropathy and fibrosis in pancreatic cancer |
| Q33285670 | Pigment epithelium-derived factor binds to cell-surface F(1)-ATP synthase. |
| Q24655238 | Pigment epithelium-derived factor binds to hyaluronan. Mapping of a hyaluronan binding site |
| Q43053809 | Pigment epithelium-derived factor expression in colorectal cancer patients |
| Q33720164 | Pigment epithelium-derived factor expression prolongs survival and enhances the cytotoxicity of low-dose chemotherapy in castration-refractory prostate cancer. |
| Q36086036 | Pigment epithelium-derived factor inhibits caveolin-induced interleukin-8 gene expression and proliferation of human prostate cancer cells. |
| Q42045623 | Pigment epithelium-derived factor inhibits lysosomal degradation of Bcl-xL and apoptosis in HepG2 cells |
| Q40137250 | Pigment epithelium-derived factor overexpression inhibits orthotopic osteosarcoma growth, angiogenesis and metastasis |
| Q35679338 | Pigment epithelium-derived factor regulates early pancreatic fibrotic responses and suppresses the profibrotic cytokine thrombospondin-1. |
| Q89606649 | Pigment epithelium-derived factor regulation of neuronal and stem cell fate |
| Q28582865 | Pigment epithelium-derived factor released by Müller glial cells exerts neuroprotective effects on retinal ganglion cells |
| Q41878827 | Pigment epithelium-derived factor restoration increases bone mass and improves bone plasticity in a model of osteogenesis imperfecta type VI via Wnt3a blockade |
| Q39856522 | Pigment epithelium-derived factor stimulates tumor macrophage recruitment and is downregulated by the prostate tumor microenvironment |
| Q26777495 | Pigment epithelium-derived factor: clinical significance in estrogen-dependent tissues and its potential in cancer therapy |
| Q39265508 | Positive correlation between PEDF expression levels and macrophage density in the human prostate |
| Q38025998 | Recessive osteogenesis imperfecta: clinical, radiological, and molecular findings |
| Q35062979 | Regulating the angiogenic balance in tissues |
| Q34346745 | Regulatory and functional connection of microphthalmia-associated transcription factor and anti-metastatic pigment epithelium derived factor in melanoma |
| Q36678182 | Restoration of the serum level of SERPINF1 does not correct the bone phenotype in Serpinf1 null mice |
| Q36000069 | Role of pigment epithelium-derived factor in stem/progenitor cell-associated neovascularization |
| Q44088705 | SERPINA3K induces apoptosis in human colorectal cancer cells via activating the Fas/FasL/caspase-8 signaling pathway |
| Q33789026 | Short pigment epithelial-derived factor-derived peptide inhibits angiogenesis and tumor growth |
| Q37597405 | The applied biochemistry of PEDF and implications for tissue homeostasis |
| Q37000498 | The effects of PEDF on cancer biology: mechanisms of action and therapeutic potential |
| Q57453895 | The effects of pigment epithelium-derived factor on atherosclerosis: putative mechanisms of the process |
| Q36084950 | The endothelial cells in islets of langerhans |
| Q36343534 | The expression of pigment epithelium-derived factor in bladder transitional cell carcinoma |
| Q38103913 | The many facets of PEDF in drug discovery and disease: a diamond in the rough or split personality disorder? |
| Q40076736 | Therapeutic potential of novel modulators of neovascularization |
| Q36786067 | Therapeutic targets of multiple angiogenic factors for the treatment of cancer and metastasis |
| Q39705442 | Thrombospondin-1 regulates the normal prostate in vivo through angiogenesis and TGF-beta activation |
| Q30499092 | Transplanting normal vascular proangiogenic cells to tumor-bearing mice triggers vascular remodeling and reduces hypoxia in tumors |
| Q33487856 | Unfavorable prognostic value of human PEDF decreased in high-grade prostatic intraepithelial neoplasia: a differential proteomics approach |
| Q24306415 | Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis |
| Q39885271 | cDNA microarray analysis of pigment epithelium-derived factor-regulated gene expression profile in prostate carcinoma cells |
Search more.